AXL inhibitor SGI-7079 suppresses the growth of retinoblastoma via PI3K/AKT/mTOR pathway
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Ocular Oncology and Treatments
PI3K/AKT/mTOR signaling in cancer
Retinal Development and Disorders
Publication details
- Journal / source
- Experimental Eye Research
- Volume
- 268
- Pages
- 110993–110993
- Publication date
- 31 March 2026
- Language
- EN